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Abstract: Cardiac Resynchronization therapy has become an important management tool in adults with heart failure and 
dilated cardiomyopathy. The role of CRT in children with CHF is still unclear. Evidence is slowly emerging in the 
pediatric cardiology literature that CRT may have an important and useful role in certain select populations with CHF. 
These include patients with complete heart block who develop pacing-induced cardiomyopathy, certain forms of 
congenital heart disease associated with systemic ventricular failure (even if the systemic ventricle is a morphologic RV) 
and in patients with idiopathic dilated cardiomyopathy. Studies in children supporting the use of CRT include many case 
reports, a few studies of CRT in post-operative patients, and one multi-center registry reporting the use of CRT in 
children. These papers will be summarized. 
INTRODUCTION 
  Cardiac asynchrony, characterized by intraventricular 
and interventricular conduction delay, may compromise 
diastolic filling, increase mitral and tricuspid valve regur-
gitation, worsen ventricular dilation, and impair cardiac 
output [1-5]. It has been long postulated that cardiac resyn-
chronization therapy (CRT) increases the efficiency of 
muscular contraction and thus augments cardiac output. CRT 
is achieved by synchronizing the  sequence of mechanical 
ventricular activation in patients with asynchronous ventri-
cular contraction. CRT has now been well established as 
having a mortality benefit in adult patients with dyssyn-
chronous left ventricle (LV) contraction and advanced 
congestive heart failure and the implantation of CRT systems 
is routinely applicable in these patients [6-8].  
  In children and patients with congenital heart disease 
(CHD), cardiac dysfunction is a major cause of morbidity 
and mortality. Questions remain unanswered  pertaining to 
the actual value of CRT in this patient population. Only 
recently have trials started to look at the beneficial effects of 
cardiac resynchronization therapy in this subset of patients.  
INDICATIONS FOR CARDIAC RESYNCHRONIZA-
TION THERAPY IN CHILDREN 
  Indications for CRT in adults include patients with New 
York Heart Association (NYHA) class III/IV heart failure, 
ejection fraction <35% and QRS duration >120ms. The strict 
application of these criteria in the pediatric and congenital 
population has many limitations. The NYHA classification 
criteria are designed for adults, not children. Estimation of 
ejection fraction in patients with complex anatomies is 
difficult. The morphologic right ventricle (RV) may be 
systemically positioned and more prone to dysfunction or 
only one functional yet failing ventricle may be present. The  
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QRS duration varies with age such that there may be 
significant mechanical dyssynchrony despite a QRS duration 
<120ms in a child. Even in adults with heart failure, all 
patients with a ventricular conduction abnormality may not 
benefit from CRT and some patients with a normal QRS 
duration  derive benefit from this therapy [9]. Electrically 
measured ventricular dyssynchrony by ECG may be looked 
at as a relatively crude reflection of mechanical ventricular 
dyssynchrony.  Unlike their adult counterparts with heart 
failure where LV dyssynchrony and a left bundle branch 
block (LBBB) is usually observed, RV dyssynchrony and a 
right bundle branch block (RBBB) is much more common in 
children. Therefore, although there are relatively few 
pediatric patients who would meet the adult CRT criteria, 
there remains a subset of younger patients with intrinsic or 
acquired conduction delay who could benefit from this 
technology. 
  Based on the adult literature, children with a dilated 
cardiomyopathy and dyssynchronous ventricular contraction 
would be an ideal subset of patients to benefit from CRT. 
Idiopathic dilated cardiomyopathy in children has a high rate 
of mortality. In patients with severe dilated cardiomyopathy 
who fail to respond to conventional medical therapy, CRT 
may prevent or prolong a cardiac transplant in some patients. 
Surgical repair may also contribute to ventricular 
asynchrony. 
  Patients with single ventricle physiology are at risk of 
developing heart failure, associated with increased mortality. 
Myocardial dysfunction remains the leading cause of death 
after stage I Norwood palliation and following the Fontan 
procedure [10-12]. In a subcohort of patients with single 
ventricles followed for a median of 17 years post Fontan 
palliation, 40% developed congestive heart failure and 18% 
died [13]. 
  Complete heart block, both congenital and acquired, is 
the single most common indication for pacing in children. 
These patients are routinely paced from the RV. Evidence is 
mounting that conventional pacing in the RV might have 
detrimental effects [14-16]. The Dual Chamber and VVI 
Implantable Defibrillator (DAVID), the Mode Selection 
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shown that right ventricular (RV) apical pacing has 
deleterious effects on LV function, most likely as a result of 
inducing LV dysynchrony [14,16,17]. Kim et al. reported the 
incidence of left ventricular dysfunction in patients with 
congenital complete AV block in those who have been paced 
for more than 10 years to be around 10% [18]. Thus in 
patients with complete heart block, it may be important to 
restore not only appropriate AV synchrony but also to 
preserve the process of cardiac mechanical activation. 
REVIEW OF LITERATURE 
Adult Literature 
  The first case report introducing the concept of CRT for 
treatment of congestive heart failure was published in 1994 
[19]. CRT in the management of CHF was subsequently 
validated in two randomized adult trials. MUSTIC [20], the 
first trial, compared in a single-blind, 3  3 months crossover 
design active versus inactive biventricular stimulation in a 
group of patients in sinus rhythm and another group in atrial 
fibrillation. Both phases of the trial demonstrated significant 
positive effects  conferred by CRT. The number of 
hospitalizations for management of CHF was decreased by 
2/3, and 85% of patients  preferred the atrio-biventricular 
over the inactive stimulation  mode. These results were 
amply confirmed by the MIRACLE trial [21] which showed 
reverse remodeling with CRT and the COMPANION trial 
[22] which found that in patients with advanced heart failure 
and a prolonged  QRS interval, cardiac-resynchronization 
therapy decreased the combined risk of death from any cause 
or first hospitalization  and, when combined with an 
implantable defibrillator, significantly reduced mortality. 
Acute Postoperative CRT 
  Initial studies in children and patients with CHD used 
temporary stimulation in the post-operative period to assess 
the benefits of CRT. Janousek et al. [23] showed that CRT 
increased systolic blood pressure in post-operative pediatric 
patients with biventricular repairs and intraventricular 
conduction delay. This group found that an increase in blood 
pressure positively correlated with initial QRS duration and 
extent of QRS shortening. Zimmerman et al. [24] examined 
the effect of resynchronization therapy on the post-operative 
pediatric patient after surgical repair. This group also found 
improvement in systolic blood pressure and cardiac index 
and a decrease in QRS duration. Pham et al. [25] recently 
reported results at odds with previously discussed studies. 
They found no change in systolic blood pressure either with 
conventional dual-chamber pacing or biventricular pacing 
when compared with baseline conditions. However, unlike 
the three aforementioned studies, this study did not have 
significant baseline intraventricular conduction delay (mean 
QRS duration of 95 ± 18 ms vs. a median QRS duration of 
120 ms in the Janousek et al. study). It is possible that 
biventricular pacing did not improve blood pressure in these 
patients as they may have been too well synchronized at 
baseline.  
CRT in Right Bundle Branch Block 
  Prolonged QRS duration is a marker of increased sudden 
death risk in tetralogy of Fallot. RV pacing decreases QRS 
duration, potentially offering RV resynchronization in 
patients with baseline RBBB. This form of CRT is by RV 
and not Bi-ventricular pacing. 
 Stephenson  et al. explored electrical resynchronization 
by RV pacing and AV interval optimization in 28 patients 
with tetralogy of Fallot and RBBB [26]. Overall, QRS 
duration was significantly shorter with right ventricular 
pacing compared to unpaced rhythms (140 ± 30 ms versus 
170 ± 20 ms). Hemodynamics were, however, not assessed 
and the clinical significance of these findings was not 
determined. 
  Electrical resynchronization was further assessed in 7 
patients with RV dysfunction and RBBB by Dubin et al. 
[27]. Transvenous pacing catheters were positioned in the 
right atrium and RV. The AV interval was programmed to 
90% of the PR interval. RV pacing sites included apex, 
outflow tract, and septum. Overall, sequential AV pacing 
improved cardiac output and RV dP/dt and decreased QRS 
duration when compared to atrial pacing alone and normal 
sinus rhythm. There was a strong relationship between 
degree of QRS improvement and increase in cardiac output. 
CRT in Systemic Right Ventricle 
  In congenital heart disease with two functional ventricles, 
the RV is systemic in congenitally corrected (L-TGA) and 
complete (D-TGA) transposition of the great arteries with 
intraatrial baffle repair. Although arterial switch surgery has 
supplanted atrial correction as the procedure of choice for D-
TGA, thereby restoring the LV to its systemic position, the 
large majority of adults with D-TGA have had atrial switch 
procedures. Over one third develop moderate to severely 
depressed systemic right ventricular function and impaired 
exercise tolerance [28]. In a large cohort, clinical heart 
failure was recognized in 22% with D-TGA and intraatrial 
baffles and in 32% with L-TGA [29]. The systemic ventri-
cular ejection fraction was significantly lower in sympto-
matic  (35 ± 16%)  compared  to  asymptomatic  (47 ± 13%) 
patients. Moreover, at 15.7 years of follow-up, mortality was 
47% in symptomatic patients compared to 5% in asympto-
matic patients. 
  CRT for systemic right ventricular dysfunction was first 
reported in a 24 year-old man with L-TGA, ventricular septal 
defect, and pulmonary atresia with NYHA class III 
symptoms and severe biventricular dysfunction [30]. 
Transvenous CRT resulted in improvement of symptoms to 
NYHA class I, decrease in ventricular dimensions, and 
improvement in fractional shortening within 1 month of 
institution. 
 Janousek  et al. assessed the hemodynamic benefits of 
CRT in 8 patients with systemic RVs [31]. Two had RBBB 
and 6 had left ventricular pacing-induced conduction delay 
with a QRS interval of 161  ±  21 ms. Six had CRT for 
systemic right ventricular dysfunction despite standard 
medical therapy and 2 received CRT as a preventive measure 
during thoracotomy for another indication. Change from 
baseline rhythm to CRT was accompanied by a decrease in 
QRS duration, reduction in interventricular mechanical 
delay, and immediate improvement in right ventricular 
filling time, Tei index (isovolumic relaxation time plus 
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maximum right ventricular dP/dt, and aortic velocity time 
integral. Right ventricular ejection fraction assessed by 
radionuclide ventriculography increased by 10% on average. 
On follow-up, right ventricular fractional area of change 
increased from 18% prior to resynchronization to 30% at 
17.5 months.  
Single Ventricle 
  The objective of CRT in single ventricles is not 
biventricular but intraventricular resynchronization through 
multisite pacing. Techniques such as 3D echocardiography 
are proving useful in assessing synchronization of individual 
contracting segments in patients with single ventricles 
[32,33]. Multisite pacing was assessed in the acute 
postoperative setting in 26 patients, with single ventricles 
undergoing some form of surgical palliation [34]. With 
multisite pacing, QRS duration decreased in 24 of 26 
patients (94 versus 72 ms), systolic blood pressure increased 
in 25 of 26 patients (86 versus 94 mmHg), cardiac index 
increased in 21 of 22 patients (3.2 versus 3.7 L/min/m 2 
versus), and 3D echocardiographic index of synchrony 
improved in 8 of 10 patients (10.3 vs. 6.0). Senzaki et al. 
described a case report of an 18 year old patient with a single 
ventricle who was repeatedly hospitalized for heart failure 
and cyanosis and deemed inoperable [35]. Institution of CRT 
resulted in improvement in NYHA from class IV to II and 
ejection fraction from 20% to 45%. 
Permanent CRT 
  Because CRT has only been recently instituted in this 
patient population, there is limited data on its long term 
benefits. Strieper et al. [36] describe the early clinical 
benefits of CRT in a select group of seven pediatric patients 
with severe congestive heart failure symptoms and con-
genital heart disease referred for consideration of cardiac 
transplantation for refractory ventricular dysfunction. 
Epicardial and endocardial left ventricular leads were 
implanted in 4 and 3 patients, respectively. Epicardial 
systems were used as an upgrade to existing epicardial leads 
or when smaller patient size precluded introducing trans-
venous leads. At a median of 19 months, 1 patient died, 1 
had cardiac transplantation, and 5 were removed from 
transplant consideration because of symptomatic improve-
ment. These patients experienced a narrowing of QRS 
duration, decreased LV end-systolic and end-diastolic 
dimensions, and an improvement in LV ejection fraction 
from 16% to 36%. Four of 5 patients with improvement in 
clinical status had previously undergone pacing for acquired 
or congenital AV block.  
 Dubin  et al. [37], in a multicenter study with 22 
institutions, evaluated the short-term (Median duration of 
follow-up: 4 months, range 22 days to 1 year) safety and 
efficacy of CRT in 103 children and CHD patients. CRT 
resulted in a significant shortening of the QRS duration and 
improvement in systemic ventricular ejection fraction. Of 18 
patients who underwent CRT while listed for heart 
transplantation, 3 improved sufficiently to allow removal 
from the transplant waiting list. They concluded that 
although this population differed substantially from the adult 
population, CRT appeared to offer substaintial benefit. Moak 
et al. [38] sought to demonstrate the benefits of CRT on 
improvement in cardiac function and clinical outcome in 
young patients that developed congestive heart failure (CHF) 
and DCM following cardiac pacing for AV block. They 
reviewed six patients who developed CHF or low cardiac 
output symptoms and DCM following implantation of right 
ventricular (RV)-based pacing systems for AV block, and 
subsequently underwent CRT. CRT proved benefitial for 
young patients that developed CHF and DCM following RV 
pacing for AV block. Based on their results, they suggested 
early upgrading to biventricular pacing in the management of 
these patients. Janousek et al. reported two cases of children 
with complete heart block with a dual-chamber right ventri-
cular-based pacemaker that developed dilated cardiomyo-
pathy with severe septal to left ventricular free-wall 
dyssynchrony . Within 4 weeks of biventricular pacing, both 
children showed significant improvement in left ventricular 
function along with reverse remodeling [39]. Khairy et al. 
[40] evaluated the effects of CRT in 13 children with CHD 
over an average of 16.5 ± 10.1 months. They demonstrated 
hemodynamic improvement with an improve-ment in 
ejection fraction and dP/dt over time. 
Technological Considerations  
  Children and patients with congenital heart disease 
comprise a heterogeneous patient population with technical 
limitations for CRT device implantation. Patient size, 
vascular access issues, and unique forms of ventricular 
asynchrony make the selection of potential beneficiaries 
challenging. Percutaneous, transvenous implantation of the 
leads may be difficult or impossible in patients with complex 
anatomies. The other option is to implant LV leads for CRT 
epicardially via a thoracotomy. This is a cumbersome and 
complicated procedure especially for patients with scar tissue 
from previous surgeries. Reports have described some novel 
approaches to implanting leads in patients with CHD 
[41,42]. Innovative tools such as noninvasive imaging of 
cardiac venous anatomy with 64-slice multi-slice computed 
tomography and noninvasive assessment of left ventricular 
dyssynchrony by 3-dimensional tissue synchronization 
imaging in patients with heart failure scheduled for cardiac 
resynchronization therapy may result in acute improvement 
of LV dyssynchrony and systolic function after CRT 
implantation [43]. 
CONCLUSION 
  Although there are no prospective and randomized trial 
data, retrospective series show that CRT is similarly 
effective for managing dyssynchrony-associated heart failure 
in this younger population as it is for treating adults with 
ischemic and idiopathic dilated cardiomyopathy. Cardiac 
resynchronization therapy, although offering significant 
benefit to some patients, is clearly not for everybody. As is 
the case for many medical innovations, the details of patient 
selection are key to the successful deployment of this new 
treatment modality. Further work is necessary to delineate, in 
this complex and heterogenous group of patients, who will 
benefit and who will not.  
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